1Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles(SLN) for controlled drug delivery-drug release and release mechanism[J].Eur J Pharm Biopharm,1998,45(2) : 149.
2Zara G P, Bargoni A, Cavalli R, et al. Pharmacokinetics and tissue distribution of idarubicin - loaded solid lipid nanoparticles after duodenal administration to rats[J] .J Pharm Scien ,2002,91(5) : 1 324.
3Miglietta A, Cavalli R ,Bocca C, et al. Cellular uptake and cytotoxicity of solid lipid nanospheres incorporation doxorubicin or paclitaxel [ J ] . lnt J Pharm , 2000,210(1-2) :61.
4Westesen K,Bunjes H,Koch MHJ .Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentia[J] .J Control Release, 1997,48(2-3) :223.
5Heiati H,Tawashi R,Phillips NC.Drug retention and stability of solid lipid, nanoparticles containing azidothymidinepalmitate after autoclaving,storage and lyophilization [J] .J Microencapsul, 1998,15(2) : 173.
6Cavalli R ,Gasco MR ,Barresi AA, et al .Evaporative drying of aqueous dispersions of solid lipid nanoparticles[J]. Drug Dev Ind Pharm , 2001,27(9) : 919.
7Beck RCR, Pohlmann AR, Hoffmeister C, et al. Dexamethasone loaded nanoparticle- coated microparticles:Correlation between in vitro drug release and drug transport across Caco 2 cell monolayers[J] .J Pharma Biopharma, 2007,67(1) : 18.
8Zhang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel - loaded poly(lactide), tocopherylpolyethylene glycol succinate nanoparticles[J].Biomaterials, 2006,27(21) : 4 025.
9Paterakis GS,Tsavaris N,Loukopoulos D.The effect of GM-CSF on reticulocytes,haemoglobin and haematocrit in patlents receiving chemotherapy for solid tumours[J].Clin Lab Hematol,1996,18(1):7.
10Hovgaard D,Mortensen BT,Schifter S,et al.Clinical pharmacokinetic studies of a human haemopoietic growth factor,GM-CSF[J].Eur J Clin Invest,1992,22(1):45.
